Modern Art Study 1 |
Style and formal elements of art |
Unfinished |
2011-01-19 |
rmr31 |
64 |
0 |
edit |
|
HAP2 Quiz 1 |
Vocab Quiz 1 |
Unfinished |
2021-08-26 |
rmr31 |
47 |
3 |
edit |
|
HAP2 Vocab Quiz 2 |
Anatomy & Physiology 2 vocab |
Unfinished |
2021-08-26 |
rmr31 |
48 |
1 |
edit |
|
HAP 2 Quiz 3 |
Vocab quiz 3 |
Unfinished |
2011-03-13 |
rmr31 |
48 |
0 |
edit |
|
HAP 2 Quiz 4 |
HAP 2 Quiz 4 |
Unfinished |
2011-03-28 |
rmr31 |
62 |
0 |
edit |
|
HAP 2 Quiz 5 |
Anatomy 2 vocab Quiz 5 |
Unfinished |
2011-04-07 |
rmr31 |
61 |
0 |
edit |
|
Anatomy vocab quiz 6 |
Vocab Quiz 6 |
Unfinished |
2011-05-09 |
rmr31 |
69 |
0 |
edit |
|
IBHS II LAB Q2 |
Ch 7 (178 bottom-188) |
Unfinished |
2013-02-07 |
rmr31 |
71 |
0 |
edit |
|
Top 200 (1-20) |
Top 200 prescription medications |
Unfinished |
2012-12-11 |
rmr31 |
20 |
0 |
edit |
|
Top 200 (1-20) Use |
Top 200 Brand/Generic Names and Uses |
Unfinished |
2012-09-02 |
rmr31 |
20 |
0 |
edit |
|
Top 200 (21-40) |
21-40 Brand/Generic |
Unfinished |
2012-09-07 |
rmr31 |
20 |
0 |
edit |
|
Top 200 (21-40) Use |
Top 21-40 Generic:Brand and Uses |
Unfinished |
2012-09-07 |
rmr31 |
20 |
0 |
edit |
|
Top 200 (41-60) |
Top 200 (41-60) Generic/Brand |
Unfinished |
2012-09-07 |
rmr31 |
20 |
0 |
edit |
|
Top 200 (41-60) Use |
Top 200 (41-60) Generic : Brand / Use |
Unfinished |
2012-09-07 |
rmr31 |
20 |
0 |
edit |
|
Top 200 (61-80) |
Top 200 (61-80) Generic / Brand |
Unfinished |
2012-09-07 |
rmr31 |
20 |
0 |
edit |
|
Top 200 (61-80) Use |
Top 200 (61-80) Generic : Brand / Use |
Unfinished |
2012-09-07 |
rmr31 |
20 |
0 |
edit |
|
Top 200 (81-100) |
Top 200 (81-100) Generic / Brand |
Unfinished |
2012-09-07 |
rmr31 |
20 |
0 |
edit |
|
Top 200 (81-100) Use |
Top 200 (81-100) Generic : Brand / Use |
Unfinished |
2012-09-07 |
rmr31 |
20 |
0 |
edit |
|
(1-20) Institutional |
1-20 Institutional Generic/Brand |
Unfinished |
2012-09-17 |
rmr31 |
20 |
0 |
edit |
|
(1-20)Institutional2 |
1-20 Institutional Generic : Brand / Use |
Unfinished |
2012-09-18 |
rmr31 |
20 |
0 |
edit |
|
1-5 OTC |
1-5 OTC Brand/Generic |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
1-5 OTC2 |
1-5 OTC Brand : Generic / Use |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
6-10 OTC |
6 - 10 OTC Brand/Generic |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
6-10 OTC2 |
6 -10 OTC Brand : Generic / Use |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
11-15 OTC |
11 - 15 OTC Brand/Generic |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
11-15 OTC2 |
11-15 OTC Brand : Generic / Use |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
16 - 20 OTC |
16-20 OTC Brand/Generic |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
16-20 OTC2 |
16-20 OTC Brand : Generic / Use |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
21 - 25 OTC |
21-25 OTC Brand/Generic |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
21 - 25 OTC2 |
21-25 OTC Brand : Generic / Use |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
26-30 OTC |
26-30 OTC Brand/Generic |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
26-30 OTC2 |
26-30 OTC Brand : Generic / Use |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
31-35 OTC |
31-35 OTC Brand/Generic |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
31-35 OTC2 |
31-35 OTC Brand : Generic / Use |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
36-40 OTC |
36 - 40 OTC Brand/Generic |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
36-40 OTC2 |
36 - 40 OTC Brand : Generic / Use |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
41-45 OTC |
41-45 OTC Brand / Use |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
46 - 50 OTC |
46 -50 OTC Brand / Use |
Unfinished |
2012-09-17 |
rmr31 |
5 |
0 |
edit |
|
Top 200 (101-120) |
Top 200 (101-120) Generic / Brand |
Unfinished |
2012-09-17 |
rmr31 |
20 |
0 |
edit |
|
Top 200(101-120) Use |
Top 200 (101-120) Generic : Brand / Use |
Unfinished |
2012-09-17 |
rmr31 |
20 |
0 |
edit |
|
Top 200 (121-140) |
Top 200 (121-140) Generic / Brand |
Unfinished |
2012-09-17 |
rmr31 |
20 |
0 |
edit |
|
Top 200(121-140) Use |
Top 200 (121-140) Generic : Brand / Use |
Unfinished |
2012-09-17 |
rmr31 |
20 |
0 |
edit |
|
IBHS LAB Q8 |
Table 12-5 and ch 13 |
Unfinished |
2012-11-02 |
rmr31 |
47 |
0 |
edit |
|
Top 200 (141-160) |
Top 200 (141-160) Generic / Brand |
Unfinished |
2012-11-05 |
rmr31 |
20 |
0 |
edit |
|
Top200 (141-160) Use |
Top 200 (141-160) Generic : Brand / Use |
Unfinished |
2012-11-28 |
rmr31 |
20 |
0 |
edit |
|
Top 200 (161-180) |
Top 200 (161-180) Generic / Brand |
Unfinished |
2012-11-05 |
rmr31 |
20 |
0 |
edit |
|
Top200 (161-180) Use |
Top 200 (161-180) Generic : Brand / Use |
Unfinished |
2012-11-05 |
rmr31 |
20 |
0 |
edit |
|
Top200 (181-200) |
Top 200 (181-200) Generic / Brand |
Unfinished |
2012-11-05 |
rmr31 |
20 |
0 |
edit |
|
Top200 (181-200) Use |
Top 200 (181-200) Generic : Brand / Use |
Unfinished |
2012-11-05 |
rmr31 |
20 |
0 |
edit |
|
IBHS2 E1 L1 |
IBHS2 Exam 1 Lecture 1 Neurons and Synapses |
Unfinished |
2012-11-07 |
rmr31 |
34 |
0 |
edit |
|
IBHS LAB Q9 |
Ch13 pg 324(bottom) - 332 & Lab Protocol 9 |
Unfinished |
2012-11-15 |
rmr31 |
87 |
0 |
edit |
|
IBHS E2 L6 |
IBHS2 Exam 2 Lecture 6 Spinal Cord |
Unfinished |
2012-11-18 |
rmr31 |
61 |
0 |
edit |
|
IBHS E2 L7 |
IBHS2 Exam 2 Lecture 7 Brain: Structure and Function |
Unfinished |
2012-11-28 |
rmr31 |
33 |
0 |
edit |
|
IBHS II LAB Q1 |
Ch 7 (165-178 Top) |
Unfinished |
2013-01-17 |
rmr31 |
102 |
0 |
edit |
|
Intr to Pat Asse Q1A |
Quiz 1 : Sig codes |
Unfinished |
2013-09-22 |
rmr31 |
91 |
0 |
edit |
|
Intr to Pat Asse Q1C |
Quiz 1 : Normal Lab Values (Na - RR) |
Unfinished |
2013-09-03 |
rmr31 |
29 |
0 |
edit |
|
Int to Pat Asse Q1B |
Quiz 1 : ISMP Do not use abbreviations (μg - UD) |
Unfinished |
2013-09-16 |
rmr31 |
28 |
0 |
edit |
|
Intr to Pat Asse Q2A |
Quiz 2 : Normal Lab Values (ABG:pH - Urinalysis: Casts) |
Unfinished |
2013-10-06 |
rmr31 |
32 |
0 |
edit |
|
Intr to Pat Asse Q2B |
Quiz 2 : Medical Abbreviations pg 1-3 |
Unfinished |
2013-10-04 |
rmr31 |
162 |
0 |
edit |
|
Intr to Pat Asse Q3C |
Quiz 3 : Medical Abbreviations pg 4-7, any labs, ISMP, sig codes are fair game |
Unfinished |
2013-10-07 |
rmr31 |
212 |
0 |
edit |
|
Cardiovascular 1 |
Cardiovascular Exam 1 Drugs |
Unfinished |
2014-02-01 |
rmr31 |
64 |
0 |
edit |
|
Respiratory |
Respiratory Exam 1 COPD Drugs |
Unfinished |
2014-02-06 |
rmr31 |
23 |
0 |
edit |
|
Respiratory 2 |
Respiratory Exam 1 Smoking Cessation Drug Info |
Unfinished |
2014-02-06 |
rmr31 |
26 |
0 |
edit |
|
Pharmacology |
Assignment 1 & 2: Trade/Generic |
Unfinished |
2019-08-13 |
rmr31 |
8 |
0 |
edit |
|
Pharmacology 2 |
Assignment 3 & 4: Trade/Generic |
Unfinished |
2019-08-13 |
rmr31 |
9 |
0 |
edit |
|
Pharmacology 3 |
Assignment 5, 6, & 7: Trade/Generic |
Unfinished |
2019-08-13 |
rmr31 |
7 |
0 |
edit |
|
Pharmacology 4 |
Assignment 8, 9, & 10: Trade/Generic |
Unfinished |
2019-08-13 |
rmr31 |
5 |
0 |
edit |
|